CRISPR

CRISPR1-tpo

ID
ZDB-CRISPR-220919-1
Name
CRISPR1-tpo
Previous Names
None
Target
Sequence
5' - GGGGTCCGCCAACACCGGCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf3605 tpo
Expression
Gene expression in Wild Types + CRISPR1-tpo
No data available
Phenotype
Phenotype resulting from CRISPR1-tpo
No data available
Phenotype of all Fish created by or utilizing CRISPR1-tpo
Phenotype Fish Conditions Figures
whole organism weight, ameliorated tpozf3605/zf3605 (TU) chemical treatment by environment: L-thyroxine Fig. 4 from Fang et al., 2022
endocrine system has extra parts of type thyroid follicle, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
pericardial cavity erythematous, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
melanophore stripe has number of melanocyte, ameliorated tpozf3605/zf3605 (TU) chemical treatment by environment: L-thyroxine Fig. 4 from Fang et al., 2022
whole organism pax4 expression decreased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
thyroid follicle tg expression increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
thyroid follicle tg expression increased distribution, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
melanophore stripe has extra parts of type melanocyte, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 3Fig. 4 from Fang et al., 2022
whole organism glucose increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
whole organism tshba expression increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
scale decreased width, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 3 from Fang et al., 2022
whole organism ins expression decreased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
anterior chamber swim bladder uninflated, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 3 from Fang et al., 2022
whole organism gcga expression increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
whole organism decreased length, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2Fig. 4 from Fang et al., 2022
thyroid follicle Ab1-thyroxine labeling absent, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
whole organism decreased weight, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 4 from Fang et al., 2022
neurocranium decreased height, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 3 from Fang et al., 2022
whole organism tg expression increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
hypophysis tshba expression increased distribution, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
whole organism glucose homeostasis process quality, ameliorated tpozf3605/zf3605 (TU) chemical treatment by environment: L-thyroxine Fig. 5 from Fang et al., 2022
whole organism glucose amount, ameliorated tpozf3605/zf3605 (TU) chemical treatment by environment: L-thyroxine Fig. 5 from Fang et al., 2022
whole organism glucose homeostasis decreased process quality, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
hypophysis tshba expression increased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 2 from Fang et al., 2022
whole organism mnx1 expression decreased amount, abnormal tpozf3605/zf3605 (TU) standard conditions Fig. 5 from Fang et al., 2022
whole organism length, ameliorated tpozf3605/zf3605 (TU) chemical treatment by environment: L-thyroxine Fig. 4 from Fang et al., 2022
Citations